 | • レポートコード：QY20ST-00057 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の犬用ワクチン市場について種類別（弱毒生ワクチン、複合ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン）、用途別（6か月以下、1か月以上）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・犬用ワクチン市場の概要 ・世界の主要地域別犬用ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の犬用ワクチン市場規模2015-2026：種類別（弱毒生ワクチン、複合ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン） ・世界の犬用ワクチン市場規模2015-2026：用途別（6か月以下、1か月以上） ・犬用ワクチンの北米市場規模2015-2020 ・犬用ワクチンのヨーロッパ市場規模2015-2020 ・犬用ワクチンの中国市場規模2015-2020 ・犬用ワクチンの日本市場規模2015-2020 ・犬用ワクチンの東南アジア市場規模2015-2020 ・犬用ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・犬用ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・犬用ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Dog Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Dog Vaccines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Dog Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Dog Vaccines industry.
Based on our recent survey, we have several different scenarios about the Dog Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Dog Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Dog Vaccines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Dog Vaccines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Dog Vaccines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Dog Vaccines market. The report also includes nautical information, where it shows Dog Vaccines market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Dog Vaccines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Dog Vaccines market.
Geographical Analysis:
Based on region, the global Dog Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Dog Vaccines market are
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Segment by Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segment by Application
Below 6 Months
Above Months
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Dog Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Dog Vaccines market.
• The market share of the global Dog Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Dog Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Dog Vaccines market.
1 Dog Vaccines Market Overview
1.1 Dog Vaccines Product Scope
1.2 Dog Vaccines Segment by Type
1.2.1 Global Dog Vaccines Sales by Type (2020-2026)
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Dog Vaccines Segment by Application
1.3.1 Global Dog Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Below 6 Months
1.3.3 Above Months
1.4 Dog Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Dog Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Dog Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Dog Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Dog Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Dog Vaccines Industry
1.5.1.1 Dog Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Dog Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Dog Vaccines Players to Combat Covid-19 Impact
2 Dog Vaccines Estimate and Forecast by Region
2.1 Global Dog Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Dog Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Dog Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Dog Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Dog Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Dog Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Dog Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dog Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Dog Vaccines Estimates and Projections (2015-2026)
2.4.3 China Dog Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Dog Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Dog Vaccines Estimates and Projections (2015-2026)
2.4.6 India Dog Vaccines Estimates and Projections (2015-2026)
3 Global Dog Vaccines Competition Landscape by Players
3.1 Global Top Dog Vaccines Players by Sales (2015-2020)
3.2 Global Top Dog Vaccines Players by Revenue (2015-2020)
3.3 Global Dog Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dog Vaccines as of 2019)
3.4 Global Dog Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Dog Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Dog Vaccines Players (Opinion Leaders)
4 Global Dog Vaccines Market Size by Type
4.1 Global Dog Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Dog Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Dog Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Dog Vaccines Price by Type (2014-2020)
4.2 Global Dog Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Dog Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Dog Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Dog Vaccines Price Forecast by Type (2021-2026)
5 Global Dog Vaccines Market Size by Application
5.1 Global Dog Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Dog Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Dog Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Dog Vaccines Price by Application (2015-2020)
5.2 Global Dog Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Dog Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Dog Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Dog Vaccines Price Forecast by Application (2021-2026)
3 North America Dog Vaccines Market Facts & Figures
3.2 North America Dog Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Dog Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Dog Vaccines Sales Market Share by Application (2015-2020)
4 Europe Dog Vaccines Market Facts & Figures
4.2 Europe Dog Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Dog Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Dog Vaccines Sales Market Share by Application (2015-2020)
5 China Dog Vaccines Market Facts & Figures
5.2 China Dog Vaccines Sales Market Share by Company (2015-2020)
5.3 China Dog Vaccines Sales Market Share by Type (2015-2020)
5.4 China Dog Vaccines Sales Market Share by Application (2015-2020)
6 Japan Dog Vaccines Market Facts & Figures
6.2 Japan Dog Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Dog Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Dog Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Dog Vaccines Market Facts & Figures
7.2 Southeast Asia Dog Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Dog Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Dog Vaccines Sales Market Share by Application (2015-2020)
8 India Dog Vaccines Market Facts & Figures
8.2 India Dog Vaccines Sales Market Share by Company (2015-2020)
8.3 India Dog Vaccines Sales Market Share by Type (2015-2020)
8.4 India Dog Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Dog Vaccines Business
12.1 Bayer Healthcare
12.1.1 Bayer Healthcare Dog Vaccines Corporation Information
12.1.2 Bayer Healthcare Dog Vaccines Business Overview and Total Revenue
12.1.3 Bayer Healthcare Dog Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Healthcare Dog Vaccines Products Offered
12.1.5 Bayer Healthcare Recent Development
12.2 Vetoquinol S.A
12.2.1 Vetoquinol S.A Dog Vaccines Corporation Information
12.2.2 Vetoquinol S.A Dog Vaccines Business Overview and Total Revenue
12.2.3 Vetoquinol S.A Dog Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Vetoquinol S.A Dog Vaccines Products Offered
12.2.5 Vetoquinol S.A Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Dog Vaccines Corporation Information
12.3.2 Boehringer Ingelheim Dog Vaccines Business Overview and Total Revenue
12.3.3 Boehringer Ingelheim Dog Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Dog Vaccines Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Ceva
12.4.1 Ceva Dog Vaccines Corporation Information
12.4.2 Ceva Dog Vaccines Business Overview and Total Revenue
12.4.3 Ceva Dog Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ceva Dog Vaccines Products Offered
12.4.5 Ceva Recent Development
12.5 Eli Lilly
12.5.1 Eli Lilly Dog Vaccines Corporation Information
12.5.2 Eli Lilly Dog Vaccines Business Overview and Total Revenue
12.5.3 Eli Lilly Dog Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eli Lilly Dog Vaccines Products Offered
12.5.5 Eli Lilly Recent Development
12.6 Heska Co.
12.6.1 Heska Co. Dog Vaccines Corporation Information
12.6.2 Heska Co. Dog Vaccines Business Overview and Total Revenue
12.6.3 Heska Co. Dog Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Heska Co. Dog Vaccines Products Offered
12.6.5 Heska Co. Recent Development
12.7 Merck Animal Health
12.7.1 Merck Animal Health Dog Vaccines Corporation Information
12.7.2 Merck Animal Health Dog Vaccines Business Overview and Total Revenue
12.7.3 Merck Animal Health Dog Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck Animal Health Dog Vaccines Products Offered
12.7.5 Merck Animal Health Recent Development
12.8 Merial (Sanofi)
12.8.1 Merial (Sanofi) Dog Vaccines Corporation Information
12.8.2 Merial (Sanofi) Dog Vaccines Business Overview and Total Revenue
12.8.3 Merial (Sanofi) Dog Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merial (Sanofi) Dog Vaccines Products Offered
12.8.5 Merial (Sanofi) Recent Development
12.9 Virbac
12.9.1 Virbac Dog Vaccines Corporation Information
12.9.2 Virbac Dog Vaccines Business Overview and Total Revenue
12.9.3 Virbac Dog Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Virbac Dog Vaccines Products Offered
12.9.5 Virbac Recent Development
12.10 Zoetis (Pfizer)
12.10.1 Zoetis (Pfizer) Dog Vaccines Corporation Information
12.10.2 Zoetis (Pfizer) Dog Vaccines Business Overview and Total Revenue
12.10.3 Zoetis (Pfizer) Dog Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Zoetis (Pfizer) Dog Vaccines Products Offered
12.10.5 Zoetis (Pfizer) Recent Development
13 Dog Vaccines Manufacturing Cost Analysis
13.1 Dog Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dog Vaccines
13.4 Dog Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dog Vaccines Distributors List
14.3 Dog Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dog Vaccines Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Dog Vaccines Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Dog Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Dog Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Dog Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Dog Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Dog Vaccines Sales (K Doses) by Region (2015-2020)
Table 10. Global Dog Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Dog Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Dog Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Dog Vaccines Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Dog Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Dog Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Dog Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Dog Vaccines (K Doses) of Key Companies (2015-2020)
Table 18. Global Dog Vaccines Sales Share by Company (2015-2020)
Table 19. Global Dog Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Dog Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Dog Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dog Vaccines as of 2019)
Table 22. Global Dog Vaccines Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Dog Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Dog Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Dog Vaccines Players
Table 27. Global Dog Vaccines Sales (K Doses) by Type (2015-2020)
Table 28. Global Dog Vaccines Sales Share by Type (2015-2020)
Table 29. Global Dog Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Dog Vaccines Price (K Doses) by Type (2015-2020)
Table 31. Global Dog Vaccines Sales Share by Type (2021-2026)
Table 32. Global Dog Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Dog Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Dog Vaccines Price (K Doses) by Type (2021-2026)
Table 35. Global Dog Vaccines Sales (K Doses) by Application (2015-2020)
Table 36. Global Dog Vaccines Sales Share by Application (2015-2020)
Table 37. Global Dog Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Dog Vaccines Price (K Doses) by Application (2015-2020)
Table 39. Global Dog Vaccines Sales (K Doses) by Application (2021-2026)
Table 40. Global Dog Vaccines Sales Share by Application (2021-2026)
Table 41. Global Dog Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Dog Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Dog Vaccines Price (K Doses) by Application (2021-2026)
Table 44. United States Dog Vaccines Sales (K Doses) by Company (2015-2020)
Table 45. United States Dog Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Dog Vaccines Sales (K Doses) by Type (2015-2020)
Table 47. United States Dog Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Dog Vaccines Sales (K Doses) by Application (2015-2020)
Table 49. United States Dog Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Dog Vaccines Sales (K Doses) by Company (2015-2020)
Table 51. Europe Dog Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Dog Vaccines Sales (K Doses) by Type (2015-2020)
Table 53. Europe Dog Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Dog Vaccines Sales (K Doses) by Application (2015-2020)
Table 55. Europe Dog Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Dog Vaccines Sales (K Doses) by Company (2015-2020)
Table 57. China Dog Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Dog Vaccines Sales (K Doses) by Type (2015-2020)
Table 59. China Dog Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Dog Vaccines Sales (K Doses) by Application (2015-2020)
Table 61. China Dog Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Dog Vaccines Sales (K Doses) by Company (2015-2020)
Table 63. Japan Dog Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Dog Vaccines Sales (K Doses) by Type (2015-2020)
Table 65. Japan Dog Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Dog Vaccines Sales (K Doses) by Application (2015-2020)
Table 67. Japan Dog Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Dog Vaccines Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Dog Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Dog Vaccines Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Dog Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Dog Vaccines Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Dog Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Dog Vaccines Sales (K Doses) by Company (2015-2020)
Table 75. India Dog Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Dog Vaccines Sales (K Doses) by Type (2015-2020)
Table 77. India Dog Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Dog Vaccines Sales (K Doses) by Application (2015-2020)
Table 79. India Dog Vaccines Sales Market Share by Application (2015-2020)
Table 80. Bayer Healthcare Corporation Information
Table 81. Bayer Healthcare Description and Business Overview
Table 82. Bayer Healthcare Dog Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Bayer Healthcare Dog Vaccines Product
Table 84. Bayer Healthcare Recent Development
Table 85. Vetoquinol S.A Corporation Information
Table 86. Vetoquinol S.A Description and Business Overview
Table 87. Vetoquinol S.A Dog Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Vetoquinol S.A Dog Vaccines Product
Table 89. Vetoquinol S.A Recent Development
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Dog Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Dog Vaccines Product
Table 94. Boehringer Ingelheim Recent Development
Table 95. Ceva Corporation Information
Table 96. Ceva Description and Business Overview
Table 97. Ceva Dog Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Ceva Dog Vaccines Product
Table 99. Ceva Recent Development
Table 100. Eli Lilly Corporation Information
Table 101. Eli Lilly Description and Business Overview
Table 102. Eli Lilly Dog Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Eli Lilly Dog Vaccines Product
Table 104. Eli Lilly Recent Development
Table 105. Heska Co. Corporation Information
Table 106. Heska Co. Description and Business Overview
Table 107. Heska Co. Dog Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Heska Co. Dog Vaccines Product
Table 109. Heska Co. Recent Development
Table 110. Merck Animal Health Corporation Information
Table 111. Merck Animal Health Description and Business Overview
Table 112. Merck Animal Health Dog Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Merck Animal Health Dog Vaccines Product
Table 114. Merck Animal Health Recent Development
Table 115. Merial (Sanofi) Corporation Information
Table 116. Merial (Sanofi) Dog Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Merial (Sanofi) Description and Business Overview
Table 118. Merial (Sanofi) Dog Vaccines Product
Table 119. Merial (Sanofi) Recent Development
Table 120. Virbac Corporation Information
Table 121. Virbac Dog Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Virbac Description and Business Overview
Table 123. Virbac Dog Vaccines Product
Table 124. Virbac Recent Development
Table . Zoetis (Pfizer) Corporation Information
Table . Zoetis (Pfizer) Description and Business Overview
Table . Zoetis (Pfizer) Dog Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Zoetis (Pfizer) Dog Vaccines Product
Table . Zoetis (Pfizer) Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Dog Vaccines Distributors List
Table 133. Dog Vaccines Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Dog Vaccines Product Picture
Figure 2. Global Dog Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dog Vaccines Market Share by Application in 2020 & 2026
Figure 6. Below 6 Months Examples
Figure 7. Above Months Examples
Figure 8. Global Dog Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Dog Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Dog Vaccines Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Dog Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Dog Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Dog Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Dog Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Dog Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Dog Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Dog Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Dog Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Dog Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Dog Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Dog Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Dog Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Dog Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Dog Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Dog Vaccines Players Market Share by Revenue in Dog Vaccines 2015 & 2019
Figure 26. Dog Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Dog Vaccines Revenue Share by Type (2015-2020)
Figure 28. Global Dog Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Dog Vaccines Revenue Share by Application (2015-2020)
Figure 30. Global Dog Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Dog Vaccines Sales Market Share by Type in 2019
Figure 32. United States Dog Vaccines Sales Market Share by Type in 2019
Figure 33. Europe Dog Vaccines Sales Market Share by Company in 2019
Figure 34. Europe Dog Vaccines Sales Market Share by Type in 2019
Figure 35. Europe Dog Vaccines Sales Market Share by Application in 2019
Figure 36. China Dog Vaccines Sales Market Share by Company in 2019
Figure 37. China Dog Vaccines Sales Market Share by Type in 2019
Figure 38. China Dog Vaccines Sales Market Share by Application in 2019
Figure 39. Japan Dog Vaccines Sales Market Share by Company in 2019
Figure 40. Japan Dog Vaccines Sales Market Share by Type in 2019
Figure 41. Japan Dog Vaccines Sales Market Share by Application in 2019
Figure 42. Southeast Asia Dog Vaccines Sales Market Share by Company in 2019
Figure 43. Southeast Asia Dog Vaccines Sales Market Share by Type in 2019
Figure 44. Southeast Asia Dog Vaccines Sales Market Share by Application in 2019
Figure 45. India Dog Vaccines Sales Market Share by Company in 2019
Figure 46. India Dog Vaccines Sales Market Share by Type in 2019
Figure 47. India Dog Vaccines Sales Market Share by Application in 2019
Figure 48. Bayer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Vetoquinol S.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Ceva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Heska Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Merial (Sanofi) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Virbac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Zoetis (Pfizer) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Dog Vaccines
Figure 60. Manufacturing Process Analysis of Dog Vaccines
Figure 61. Dog Vaccines Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
猫用ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Cat Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data …- デング熱ワクチンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Dengue Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dengue Vaccines market report…
- 生ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Live Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data…
- 組換えベクターワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Recombinant Vector Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides…
- 子宮頸がんワクチンの世界市場レポート2020 Cervical cancer vaccines can effectively prevent cervical cancer in women due to human papillomavirus, and the best age for cervical cancer vaccine injection is 15 years old.Depending on the immunity to the under-15s and over-15s, the cervical cancer vaccine has only a 0.2 per cent chance of develop…